Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $533.92 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $251.70 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $229.70 | 4 | $0 (2024) |
| HEARTFLOW, INC. | $30.31 | 1 | $0 (2024) |
| Abbott Laboratories | $22.21 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.64 | 6 | E.R. Squibb & Sons, L.L.C. ($148.56) |
| 2022 | $202.07 | 2 | Medtronic, Inc. ($120.93) |
| 2020 | $22.21 | 1 | Abbott Laboratories ($22.21) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $110.81 | General |
| Category: Stents | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $9.20 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.30 | General |
| 07/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Renal Denervation System | ||||||
| 06/05/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $30.31 | General |
| Category: Coronary | ||||||
| 12/12/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $81.14 | General |
| Category: Cardiovascular | ||||||
| 12/02/2022 | Medtronic, Inc. | ABRE (Device) | Food and Beverage | In-kind items and services | $120.93 | General |
| Category: Stents | ||||||
| 02/06/2020 | Abbott Laboratories | Merlin Connectivity and Remote (Device) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,668 | 5,271 | $2.3M | $262,280 |
| 2022 | 27 | 3,065 | 4,882 | $2.4M | $350,758 |
| 2021 | 26 | 2,751 | 4,934 | $2.4M | $373,149 |
| 2020 | 28 | 3,150 | 5,395 | $2.0M | $314,609 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 997 | $686,933 | $106,753 | 15.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 261 | 274 | $410,726 | $48,590 | 11.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 109 | $95,811 | $17,299 | 18.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 227 | 227 | $484,268 | $15,069 | 3.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 564 | 947 | $131,633 | $12,135 | 9.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 143 | $46,046 | $10,415 | 22.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,073 | 1,505 | $66,220 | $9,912 | 15.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 22 | 22 | $33,814 | $4,620 | 13.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $25,454 | $4,142 | 16.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 18 | 62 | $65,596 | $3,821 | 5.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 83 | $15,106 | $3,799 | 25.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 61 | 62 | $92,938 | $3,620 | 3.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 22 | $21,538 | $2,893 | 13.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 198 | 198 | $15,444 | $2,426 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $15,589 | $1,815 | 11.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $2,616 | $1,726 | 66.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $12,838 | $1,669 | 13.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 88 | 88 | $10,560 | $1,621 | 15.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 21 | $7,413 | $1,453 | 19.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 112 | 148 | $2,129 | $1,243 | 58.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 39 | 63 | $13,356 | $1,240 | 9.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 30 | 49 | $9,261 | $1,196 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 12 | $8,558 | $1,075 | 12.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 22 | 22 | $10,978 | $1,056 | 9.6% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 21 | 23 | $46,865 | $1,027 | 2.2% |
About Dr. James Catanese, M.D
Dr. James Catanese, M.D is a Cardiovascular Disease healthcare provider based in Mount Kisco, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730177478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Catanese, M.D has received a total of $533.92 in payments from pharmaceutical and medical device companies, with $309.64 received in 2024. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($533.92).
As a Medicare-enrolled provider, Catanese has provided services to 12,634 Medicare beneficiaries, totaling 20,482 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Mount Kisco, NY
- Active Since 10/06/2005
- Last Updated 07/20/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1730177478
Products in Payments
- ABRE (Device) $120.93
- ONYX FRONTIER (Device) $110.81
- CAMZYOS (Drug) $104.40
- FFRct (Device) $30.31
- Merlin Connectivity and Remote (Device) $22.21
- SYMPLICITY G3 (Device) $19.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Mount Kisco
Robert Knotts, M.d, M.D
Cardiovascular Disease — Payments: $31,835
Dr. Umar Rashid, M.d, M.D
Cardiovascular Disease — Payments: $19,670
Aglae Rene, M.d, M.D
Cardiovascular Disease — Payments: $6,570
Dr. Michelle Delvalle, M.d, M.D
Cardiovascular Disease — Payments: $1,492
Ronald Wallach, Md, MD
Cardiovascular Disease — Payments: $239.56
Mark Lieb, Md, MD
Cardiovascular Disease — Payments: $124.90